Effect of beer drinking on ultrasound bone mass in women

Nutrition

Volumn 25, Issue 10, 2009, Pages 1057-1063

  Pedrera Zamorano, Juan D ^a   Lavado Garcia, Jesus M ^a   Roncero Martin, Raul ^a   Calderon Garcia, Julian F ^a   Rodriguez Dominguez, Trinidad ^a   Canal Macias, Maria L ^a  

^a UNIVERSITY OF EXTREMADURA   (Spain)

Author keywords

Alcohol; Bone quality; Bone ultrasound; Phytoestrogens; Spanish female population

Indexed keywords

CAFFEINE; PHYTOESTROGEN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BEER; BODY MASS; BONE MASS; CALCIUM METABOLISM; CIGARETTE SMOKING; CLIMACTERIUM; CONTROLLED STUDY; FEMALE; HUMAN; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; WINE;

ADULT; AGING; ALCOHOL DRINKING; ANALYSIS OF VARIANCE; BEER; BODY MASS INDEX; BONE DENSITY; CAFFEINE; CROSS-SECTIONAL STUDIES; DIET RECORDS; FEMALE; FINGER PHALANGES; HUMANS; MIDDLE AGED; OSTEOPOROSIS; POSTMENOPAUSE; PREMENOPAUSE; QUESTIONNAIRES; SMOKING; WINE;

EID: 69249232174     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2009.02.007     Document Type: Article

References (61)

1. Taggart H.M., Chesnut C.H., Ivey J.L., Baylink D.J., Sison K., and Huber M.B. Deficient calcitonin response to calcium stimulation in postmenopausal osteoporosis?. Lancet 27 (1982) 475-478
2. Reginster J.Y., Deroisy R., Albert A., Denis D., Lecart M.P., Collette J., et al. Relationship between whole plasma calcitonin levels, calcitonin secretory capacity, and plasma levels of estrone in healthy women and postmenopausal osteoporotics. J Clin Invest 83 (1989) 1073-1077
3. Perez-Cano R., Montoya M.J., Moruno R., Vazquez A., Galan F., and Garrido M. Calcitonin reserve in healthy women and patients with postmenopausal osteoporosis. Calcif Tissue Int 45 (1989) 203-208
4. Dymling J.F., Ljungberg O., Hillyard C.J., Greenberg P.B., Evans I.M.A., and MacIntyre I. Whiskey: a new provocative test for calcitonin secretion. Acta Endocrinol 82 (1976) 500-509
5. Watanabe K., Takekoshi S., and Kakudo K. Effects of ipriflavone on calcitonin synthesis in c-cells of the rat thyroid. Calcif Tissue Int 51 suppl 1 (1992) S27-S29
6. Raisz L., Au W.Y., Friedman J., and Niemann I. Thyrocalcitonin and bone resorption. Am J Med 43 (1967) 684-690
7. Ito N., Yamazaki H., Nakazaki M., Miyahara T., Kozuka H., and Sudo H. Response of osteoblastic clonal cell line (MC3T3-E1) to (Asu 1,7) Eel calcitonin at a specific cell density or differentiation stage. Calcif Tissue Int 40 (1987) 200-205
8. Holbrook T.L., and Barrett-Connor E. A prospective study of alcohol consumption and bone mineral density. Br Med J 306 (1993) 1506-1509
9. Ilich J.Z., Brownbill R.A., Tamborini L., and Crncevic-Orlic Z. To drink or not to drink: how are alcohol, caffeine and past smoking related to bone mineral density in elderly women?. J Am Coll Nutr 21 (2002) 536-544
10. Mukamal K.J., Robbins J.A., Cauley J.A., Kern L.M., and Siscovick D.S. Alcohol consumption, bone density, and hip fracture among older adults: the cardiovascular health study. Osteoporos Int 18 (2007) 593-602
11. Uthian W.H. Comparative trial of P1496, a new nonsteroidal oestrogen. Br Med J 1 (1973) 579-581
12. Harkness L.S., Fiedler K., Sehgal A.R., Oravec D., and Lerner E. Decreased bone resorption with soy isoflavone supplementation in postmenopausal women. J Womens Health (Larchmt) 13 (2004) 1000-1007
13. Agnusdei D., Camporeale A., Zacchei F., Gennari C., Baroni M.C., Costi D., et al. Effects of ipriflavone on bone mass and bone remodeling in patients with established postmenopausal osteoporosis. Curr Ther Res 51 (1992) 82-91
14. Agnusdei D., Adami S., Cervetti R., Crepaldi G., Di Munno O., Fantasia L., et al. Effects of ipriflavone on bone mass and calcium metabolism in postmenopausal women. Bone Miner 19 suppl 1 (1992) S43-S48
15. Nakamura S., Morimoto S., Takamoto S., Onishi T., Fukuo K., Koh E., et al. Effect of ipriflavone on bone mineral density and calcium-related factors in elderly females. Calcif Tissue Int 51 suppl 1 (1992) S30-S34
16. Potter S.M., Baum J.A., Teng H., Stillman R.J., Shay N.F., and Erdman Jr. J.W. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 68 suppl (1998) S1375-S1379
17. Clifton-Bligh P.B., Baber R.J., Fulcher G.R., Nery M.L., and Moreton T. The effect of isoflavones extracted from red clover (Rimostil) on lipid and bone metabolism. Menopause 8 (2001) 259-265
18. Farley J.R., Wergedal J.E., Hall S.L., Herring S., and Tarbaux N.M. Calcitonin has direct effects on 3[H]-thymidine incorporation and alkaline phosphatase activity in human osteoblast line cells. Calcif Tissue Int 48 (1991) 297-301
19. Rosenblum E.R., Stauber R.E., Van Thiel D.H., Campbell I.M., and Gavaler J.S. Assessment of the estrogenic activity of phytoestrogens isolated from bourbon and beer. Alcohol Clin Exp Res 17 (1993) 1207-1209
20. Rosenblum E.R., Campbell I.M., Van Thiel D.H., and Gavaler J.S. Isolation and identification of phytoestrogens from beer. Alcohol Clin Exp Res 16 (1992) 843-845
21. Jugdaohsingh R., Anderson S.H., Tucker K.L., Elliott H., Kiel D.P., Thompson R.P., and Powell J.J. Dietary silicon intake and absorption. Am J Clin Nutr 75 (2002) 887-893
22. Reffitt D.M., Ogston N., Jugdaohsingh R., Cheung H.F., Evans B.A., Thompson R.P., et al. Orthosilicic acid stimulates collagen type 1 synthesis and osteoblastic differentiation in human osteoblast-like cells in vitro. Bone 32 (2003) 127-135
23. Schiano A., Eisinger F., Detolle P., Laponche A.M., Brisou B., and Eisinger J. Silicium, tissu osseux et immunité. Silicon, bone tissue and immunity. Rev Rhum Mal Osteoartic 46 (1979) 483-486
24. Eisinger J., and Clairet D. Effects of silicon, fluoride, etidronate and magnesium on bone mineral density: a retrospective study. Magnes Res 6 (1993) 247-249
25. Hott M., de Pollak C., Modrowski D., and Marie P.J. Short-term effects of organic silicon on trabecular bone in mature ovariectomized rats. Calcif Tissue Int 53 (1993) 174-179
26. Rico H., Gallego-Lago J.L., Hernandez E.R., Villa L.F., Sanchez-Atrio A., Seco C., et al. Effect of silicon supplement on osteopenia induced by ovariectomy in rats. Calcif Tissue Int 66 (2000) 53-55
27. Bellia J.P., Birchall J.D., and Roberts N.B. Beer: a dietary source of silicon. Lancet 343 (1994) 235
28. Pennington J.A. Silicon in foods and diets. Food Addit Contam 8 (1991) 97-118
29. Pedrera-Zamorano J.D., Canal-Macias M.L., Lavado-Garcia J.M., Costa-Fernandez C.C., Borrella-Dominguez S., and Rico-Lenza H. Reference curve of bone ultrasound measurements in proximal phalanges in normal Spanish women. J Clin Densitom 6 (2003) 373-380
30. Rico H., Canal M.L., Mañas P., Lavado J.M., Costa C., and Pedrera J.D. Effects of the intake of caffeine, vitamin D and other nutrients on quantitative phalangeal bone ultrasound in postmenopausal women. Nutrition 18 (2002) 89-193
31. Pedrera J.D., Canal M.L., Postigo S., Lavado J., Hernandez E.R., and Rico H. Phalangeal bone ultrasound and its possible correlation with nutrient in an area of high protein intake. Ann Nutr Metab 45 (2001) 86-90
32. U.S. Department of Agriculture, Agricultural Research Service. USDA national nutrient database for standard reference, release 19, 2006. Nutrient Data Laboratory home page. Available at: http://www.ars.usda.gov/ba/bhnrc/ndl. [Accessed March 23, 2008].
33. Gonzalez-Muñoz M.J., Meseguer-Soler I., and Peña-Fernandez A. La cerveza como fuente dietetica de silicio y su efecto protector frente a la intoxicacion por aluminio: influencia sobre la absorcion y la acumulacion de este metal neurotoxico (2006), Centro de Informacion Cerveza y Salud, Madrid
34. Barone J.J., and Roberts H.R. Caffeine consumption. Food Chem Toxicol 34 (1996) 119-129
35. Aguado F., Revilla M., Hernandez E.R., Villa L.F., and Rico H. Ultrasound bone velocity on proximal phalanges in premenopausal, perimenopausal, and postmenopausal healthy women. Invest Radiol 32 (1997) 66-70
36. Cadossi R., and Cane V. Pathways of transmission of ultrasound energy through the distal metaphysis of the second phalanx of pigs: an in vitro study. Osteoporos Int 6 (1996) 196-206
37. Wuster C., Albanese C., De Aloysio D., Duboeuf F., Gambacciani M., Gonnelli S., et al. Phalangeal osteosonogrammetry study: age-related changes, diagnostic sensitivity, and discrimination power. The Phalangeal Osteosonogrammetry Study Group. J Bone Miner Res 15 (2000) 1603-1614
38. Guglielmi G., Njeh C.F., de Terlizzi F., De Serio D.A., Scillitani A., Cammisa M., et al. Phalangeal quantitative ultrasound, phalangeal morphometric variables, and vertebral fracture discrimination. Calcif Tissue Int 72 (2003) 469-477
39. Takada M., Engelke K., Hagiwara S., Grampp S., Jergas M., Gluer C.C., et al. Assessment of osteoporosis: comparison of radiographic absorptiometry of the phalanges and dual x-ray absorptiometry of the radius and lumbar spine. Radiology 202 (1997) 759-763
40. Kleerekoper M., Nelson D.A., Flynn M.J., Pawluszka A.S., Jacobsen G., and Peterson E.L. Comparison of radiographic absorptiometry with dual-energy X-ray absorptiometry and quantitative computed tomography in normal older white and black women. J Bone Miner Res 9 (1994) 1745-1749
41. Grainge M.J., Coupland C.A., Cliffe S.J., Chilvers C.E., and Hosking D.J. Cigarette smoking, alcohol and caffeine consumption, and bone mineral density in postmenopausal women. The Nottingham EPIC Study Group. Osteoporos Int 8 (1998) 355-363
42. Milligan S.R., Kalita J.C., Pocock V., Van De Kauter V., Stevens J.F., Deinzer M.L., et al. The endocrine activities of 8-prenylnaringenin and related hop (Humulus lupulus L.) flavonoids. J Clin Endocrinol Metab 85 (2000) 4912-4915
43. Fitzpatrick L.A. Phytoestrogens-mechanism of action and effect on bone markers and bone mineral density. Endocrinol Metab Clin N Am 32 (2003) 233-252
44. Arjmandi B.H. The role of phytoestrogens in the prevention and treatment of osteoporosis in ovarian hormone deficiency. J Am Coll Nutr 20 suppl 8 (2001) S398-S402
45. Setchell K.D., and Lydeking-Olsen E. Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies. Am J Clin Nutr 78 suppl 3 (2003) S593-S609
46. Hertrampf T., Gruca M.J., Seibel J., Laudenbach U., Fritzemeier K.H., and Diel P. The bone-protective effect of the phytoestrogen genistein is mediated via ERalpha-dependent mechanisms and strongly enhanced by physical activity. Bone 40 (2007) 1529-1535
47. Anderson J.J., Ambrose W.W., and Garner S.C. Orally dosed genistein from soy and prevention of cancellous bone loss in two ovariectomized rat models. J Nutr 125 suppl 1 (1995) S799
48. Fonseca D., and Ward W.E. Daidzein together with high calcium preserve bone mass and biomechanical strength at multiple sites in ovariectomized mice. Bone 35 (2004) 489-497
49. Fanti P., Monier-Faugere M.C., Geng Z., Schmidt J., Morris P.E., Cohen D., et al. The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats. Osteoporosis Int 8 (1998) 274-281
50. Potter S.M., Baum J.A., Teng H., Stillman R.J., Shay N.F., and Erdman Jr. J.W. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 68 6 suppl (1998) 1375S-9S
51. Atkinson C., Compston J.E., Day N.E., Dowsett M., and Bingham S.A. The effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 79 (2004) 326-333
52. Somekawa Y., Chiguchi M., Ishibashi T., and Aso T. Soy intake related to menopausal symptoms, serum lipids, and bone mineral density in postmenopausal Japanese women. Obstet Gynecol 97 (2001) 109-115
53. Morabito N., Crisafulli A., Vergara C., Gaudio A., Lasco A., Frisina N., et al. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. J Bone Miner Res 17 (2002) 1904-1912
54. Wu J., Oka J., Tabata I., Higuchi M., Toda T., Fuku N., et al. Effects of isoflavone and exercise on BMD and fat mass in postmenopausal Japanese women: a 1-year randomized placebo-controlled trial. J Bone Miner Res 21 (2006) 780-789
55. Frankenfeld C.L., Atkinson C., Thomas W.K., Goode E.L., Gonzalez A., Jokela T., et al. Familial correlations, segregation analysis, and nongenetic correlates of soy isoflavone-metabolizing phenotypes. Exp Biol Med (Maywood) 229 (2004) 902-913
56. Atkinson C., Frankenfeld C.L., and Lampe J.W. Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp Biol Med (Maywood) 230 (2005) 155-170
57. Lehmann L., Esch H.L., Wagner J., Rohnstock L., and Metzler M. Estrogenic and genotoxic potential of equol and two hydroxylated metabolites of Daidzein in cultured human Ishikawa cells. Toxicol Lett 158 (2005) 72-86
58. Setchell K.D., Brown N.M., and Lydeking-Olsen E. The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J Nutr 132 (2002) 3577-3584
59. Onland-Moret N.C., Peeters P.H., van der Schouw Y.T., Grobbee D.E., and van Gils C.H. Alcohol and endogenous sex steroid levels in postmenopausal women: a cross-sectional study. J Clin Endocrinol Metab 90 (2005) 1414-1419
60. Fanti O., Faugere M.C., Gang Z., Schmidt J., Cohen D., and Malluche H.H. Systematic administration of genistein partially prevents bone loss in ovariectomized rats in a nonestrogen-like-mechanism. Am J Clin Nutr 68 suppl 1 (1998) S1517
61. Jugdaohsingh R., Tucker K.L., Qiao N., Cupples L.A., Kiel D.P., and Powell J.J. Dietary silicon intake is positively associated with bone mineral density in men and premenopausal women of the Framingham Offspring cohort. J Bone Miner Res 19 (2004) 297-307